Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Fuglesang currently holds 216,288 shares of Mirati Therapeutics, Inc. (MRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Fuglesang has been a net seller of MRTX stock. They have purchased $14.6M and sold $80.8M worth of shares.
Christopher Fuglesang's most recent insider trade was on Apr 1, 2021, when they sold 23,622 shares at $60.00 per share.
Christopher Fuglesang serves as Executive at Mirati Therapeutics, Inc. (MRTX). They have executed 12 insider transactions totaling $95.4M over their tenure at the company.
Christopher Fuglesang holds the position of Executive at Mirati Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Christopher Fuglesang has shown a selling trading pattern, with $14.6M in total purchases and $80.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Fuglesang was on Apr 1, 2021, when they sold $126.5M worth of PAND shares. This transaction involved 2,107,513 shares at $60.00 per share.
Christopher Fuglesang currently owns 216,288 shares of Mirati Therapeutics, Inc. (MRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Fuglesang's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Fuglesang has 12 Form 4 filings on record as an insider at Mirati Therapeutics, Inc..
Set alerts for Christopher Fuglesang and 40,000+ other insiders.